The impact of COVID-19 stress on pain and fatigue in people with and without a central sensitivity syndrome

por Koppert, Tim Y., Jacobs, Johannes W.G., Lumley, Mark A., Geenen, Rinie
Publicado 2021

Tocilizumab as monotherapy or combination therapy for treating active rheumatoid arthritis: a meta-analysis of efficacy and safety reported in randomized controlled trials

por Teitsma, Xavier M., Marijnissen, Anne Karien A., Bijlsma, Johannes W. J., Lafeber, Floris P. J., Jacobs, Johannes W. G.
Publicado 2016

Do we need bone mineral density to estimate osteoporotic fracture risk? A 10-year prospective multicentre validation study

por Marques, Andréa, Lucas, Raquel, Simões, Eugénia, Verstappen, Suzanne M M, Jacobs, Johannes W G, da Silva, Jose A P
Publicado 2017

Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis

por Rubbert-Roth, Andrea, Aletaha, Daniel, Devenport, Jenny, Sidiropoulos, Paris N, Luder, Yves, Edwardes, Michael D, Jacobs, Johannes W G
Publicado 2020

Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial

por Lamers-Karnebeek, Femke B G, Luime, Jolanda J, Jansen, Tim L, van Riel, Piet L C M, Jacobs, Johannes W G
Publicado 2020

Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab

por Teitsma, Xavier M., Devenport, Jenny, Jacobs, Johannes W. G., Pethö-Schramm, Attila, Borm, Michelle E. A., Budde, Petra, Bijlsma, Johannes W. J., Lafeber, Floris P. J. G.
Publicado 2020

Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotre...

por Teitsma, Xavier M., Jacobs, Johannes W. G., Mokry, Michal, Borm, Michelle E. A., Pethö-Schramm, Attila, van Laar, Jacob M., Bijlsma, Johannes W. J., Lafeber, Floris P. J.
Publicado 2017

Correspondence on “Re‐examining remission definitions in rheumatoid arthritis: considering the 28‐Joint Disease Activity Score, C‐reactive protein level and patient global assessme...

por Ferreira, Ricardo J. O., Welsing, Paco M. J., Jacobs, Johannes W. G., Gossec, Laure, Ndosi, Mwidimi, Machado, Pedro M., van der Heijde, Désirée, da Silva, José A. P.
Publicado 2022

Determining the Lowest Optimally Effective Methotrexate Dose for Individual RA Patients Using Their Dose Response Relation in a Tight Control Treatment Approach

por Nair, Sandhya C., Jacobs, Johannes W. G., Bakker, Marije F., Jahangier, Z. Nazira, Bijlsma, Johannes W. J., van Laar, Jacobs M., Lafeber, Floris P. J. G., Welsing, Paco M. J.
Publicado 2016

Efficacy of Tocilizumab Monotherapy Versus Tocilizumab and Methotrexate Combination Therapy in the Prevention of Radiographic Progression in Rheumatoid Arthritis: An Analysis Using...

por Verhoeven, Maxime M. A., Tekstra, Janneke, Jacobs, Johannes W. G., Bijlsma, Johannes W. J., van Laar, Jacob M., Pethö‐Schramm, Attila, Borm, Michelle E. A., Lafeber, Floris P. J., Welsing, Paco M. J.
Publicado 2022

Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) Scores

por Verhoeven, Maxime M. A., Westgeest, Antonius A. A., Schwarting, Andreas, Jacobs, Johannes W. G., Heller, Caroline, van Laar, Jacob M., Lafeber, Floris P. J. G., Tekstra, Janneke, Triantafyllias, Konstantinos, Welsing, Paco M. J.
Publicado 2022

Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combin...

por Teitsma, Xavier M, Yang, Wei, Jacobs, Johannes W G, Pethö-Schramm, Attila, Borm, Michelle E A, Harms, Amy C, Hankemeier, Thomas, van Laar, Jacob M, Bijlsma, Johannes W J, Lafeber, Floris P J G
Publicado 2018

Effectiveness of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protoc...

por van der Leeuw, Matthijs S., Welsing, Paco M. J., de Hair, Maria J. H., Jacobs, Johannes W. G., Marijnissen, Anne C. A., Linn-Rasker, Suzanne P., Fodili, Faouzia, Bos, Reinhard, Tekstra, Janneke, van Laar, Jacob M.
Publicado 2020

Utility of the HandScan in monitoring disease activity and prediction of clinical response in rheumatoid arthritis patients: an explorative study

por Verhoeven, Maxime M A, Tekstra, Janneke, Marijnissen, Anne C A, Meier, Anna J L, Westgeest, Antonius A A, Lafeber, Floris P J G, Jacobs, Johannes W G, van Laar, Jacob M, Welsing, Paco M J
Publicado 2021

Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate

por Verhoeven, Maxime M A, Tekstra, Janneke, Welsing, Paco M J, Pethö-Schramm, Attila, Borm, Michelle E A, Bruyn, George A W, Bos, Reinhard, Griep, Ed N, Klaasen, Ruth, van Laar, Jacob M, Lafeber, Floris P J G, Bijlsma, Johannes W J, de Hair, Marjolein J H, Jacobs, Johannes W G
Publicado 2020